BlackRock’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17M | Buy |
|
|||||
|
2025
Q1 | $3.36M | Sell |
|
|||||
|
2024
Q4 | $5.74M | Buy |
|
|||||
|
2024
Q3 | $3.19M | Buy |
|
|||||
|
2024
Q2 | $1.02M | Buy |
|
|||||
|
2024
Q1 | $931K | Buy |
|
|||||
|
2023
Q4 | $916K | Sell |
|
|||||
|
2023
Q3 | $761K | Sell |
|
|||||
|
2023
Q2 | $1.22M | Buy |
|
|||||
|
2023
Q1 | $449K | Buy |
|
|||||
|
2022
Q4 | $417K | Sell |
|
|||||
|
2022
Q3 | $411K | Sell |
|
|||||
|
2022
Q2 | $501K | Buy |
|
|||||
|
2022
Q1 | $819K | Sell |
|
|||||
|
2021
Q4 | $1.22M | Buy |
|
|||||
|
2021
Q3 | $486K | Sell |
|
|||||
|
2021
Q2 | $350K | Buy |
|
|||||
|
2021
Q1 | $239K | Buy |
|
|||||
|
2020
Q4 | $248K | Sell |
|
|||||
|
2020
Q3 | $647K | Sell |
|
|||||
|
2020
Q2 | $844K | Sell |
|
|||||
|
2020
Q1 | $664K | Buy |
|
|||||
|
2019
Q4 | $1.71M | Sell |
|
|||||
|
2019
Q3 | $1.01M | Buy |
|
|||||
|
2019
Q2 | $1.24M | Sell |
|
|||||
|
2019
Q1 | $3.71M | Sell |
|
|||||
|
2018
Q4 | $3.47M | Sell |
|
|||||
|
2018
Q3 | $10.3M | Buy |
|
|||||
|
2018
Q2 | $12.3M | Buy |
|
|||||
|
2018
Q1 | $8.5M | Buy |
|
|||||
|
2017
Q4 | $6.94M | Buy |
|
|||||
|
2017
Q3 | $6.07M | Buy |
|
|||||
|
2017
Q2 | $4.47M | Buy |
|
|||||
|
2017
Q1 | $3.71M | Buy |
|
|||||
|
2016
Q4 | $3K | Sell |
|
|||||
|
2016
Q3 | $7K | Buy |
|
|||||
|
2016
Q2 | $3K | Sell |
|
|||||
|
2016
Q1 | $174K | Buy |
|